Delivery Order SPE2DB22D3501-SPE2DB24FWB69
Award Date
6/25/24
Potential Completion Date
7/17/24
Potential Value
$42K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,999.72 firm fixed-price delivery order is for the supply of PADCEV 30 MG vials, a pharmaceutical product. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, with a ceiling value of $19,999.44, is for the provision of the pharmaceutical product PADCEV 30 MG VIALS to the Defense Logistics Agency (DLA). The contract is a Delivery Order issued under the company's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at up to $14,999.58, is for the delivery of 4565092788 PADCEV 30 MG VIALS. This is a firm fixed-price delivery order contract with a completion date of July 29, 2024. Amerisourcebergen is a major pharmaceutical distribution company that has received numerous federal contract awards to supply...
The U.S. Department of Defense (DoD) Defense Logistics Agency (DLA) awarded a $24,999.30 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of PADCEV 30 MG vials, a pharmaceutical product, with a period of performance through October 28, 2024. AmerisourceBergen is a large pharmaceutical distributor that provides a wide range of medical commodities to federal agencies, including the military. This contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $116,823.84, is for the delivery of PADCEV 30 MG VIALS, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is also...
This is a federal delivery order contract awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,695.90 firm-fixed-price contract is for the delivery of PADCEV 20 MG VIAL 1S, a pharmaceutical product, with a period of performance through June 9, 2025. The contract is not set aside for any small business or socioeconomic program. AmerisourceBergen Drug Corp also holds a much larger...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $24,338.30 firm fixed price delivery order contract to provide PADCEV 30 MG VIALS. This is a pharmaceutical product delivery order under a larger indefinite delivery contract held by Amerisourcebergen with DLA to supply pharmaceuticals and medical supplies, primarily in support of military treatment programs and facilities. The contract has a completion date of January...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,345.32, is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The award, valued at $14,298.45, is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PADCEV 30 MG vials. The contract is a firm fixed-price delivery order with a ceiling value of $39,998.88 and is set to be completed by September 5, 2024. Amerisourcebergen is providing these critical pharmaceutical products to support military treatment facilities and other federal healthcare providers. This delivery order is part...